Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Cue Biopharma, Inc.

NASDAQ: CUE · Life Sciences · 5 alerts · CIK 1645460

Share price
$14.10Close, Nov 16
Market cap
$102M
Shares outstanding
7.26MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Cue Biopharma, Inc. filings on SEC EDGAR ↗

9:40 PM ET Form 4
Insider Selling

Cue Biopharma Chief Legal Compliance Officer Sumita Ray Sells $51.7K of Stock

Sumita Ray, Chief Legal Compliance Officer, sold 1,844 shares of Cue Biopharma, Inc. at $28.05 a share, worth $51.7K in total on Oct 12, 2026. Shares held after the trade: 116,701 (-1.6%).

Value
$51.7K
Shares
1,844
Price
$28.05
Role
Chief Legal Compliance Officer
Holding change
-1.6%
Trade date
Oct 12, 2026
9:38 PM ET Form 4
Insider Selling

Cue Biopharma VP, Prin. Accounting Officer Michael Vincent Meluzio Sells $32.1K of Stock

Michael Vincent Meluzio, VP, Prin. Accounting Officer, sold 1,144 shares of Cue Biopharma, Inc. at $28.05 a share, worth $32.1K in total on Oct 12, 2026. Shares held after the trade: 47,817 (-2.3%).

Value
$32.1K
Shares
1,144
Price
$28.05
Role
VP, Prin. Accounting Officer
Holding change
-2.3%
Trade date
Oct 12, 2026
9:37 PM ET Form 4
Insider Selling

Cue Biopharma CEO Shao-Lee Lin Sells $305K of Stock

Shao-Lee Lin, CEO, sold 11,087 shares of Cue Biopharma, Inc. at $27.50 to $28.05 a share (average $27.55) in 2 transactions, worth $305K in total on Oct 12, 2026. Shares held after the trade: 694,908 (-0.2%).

Value
$305K
Shares
11,087
Average price
$27.55
Role
CEO
Holding change
-0.2%
Trade date
Oct 12, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.